Retroscreen Virology is Europe’s leading specialist virology contract research organisation (CRO). The work we conduct is dedicated to creating the next generation of antivirals and vaccines for a number of respiratory and enteric viral diseases. Our research ranges from pre-clinical (analytical) services through first-into-man (Phase 1a) studies and into human challenge studies (Phase 1b and Phase 2a proof-of-concept).
Experimental challenge studies, where healthy volunteers are infected with virus so that novel antivirals and vaccines can be assessed in a controlled manner, can rapidly reduce the time and cost of drug development by accelerating the selection of safe and effective dose and dosing regimes.
We currently conduct and co-ordinate several clinical trials per year particularly involving influenza, RSV or common cold viruses. Please contact us on the number below or browse our website for more information.
Contact us on +44 (0)20 7118 0727
Latest News
